Wolfe Research raised the firm’s price target on Houlihan Lokey (HLI) to $155 from $145 and keeps an Underperform rating on the shares as part ...

Houlihan Lokey HLI has outperformed the market over the past 5 years by 15.51% on an annualized basis producing an average ...

Shares of Houlihan Lokey, Inc. (NYSE:HLI – Get Free Report) have been given an average recommendation of “Reduce” by the six ...

Oceans Healthcare has announced the acquisition of all outstanding shares of Nashville-based Haven Behavioral Healthcare.

According to Benzinga Pro, Houlihan Lokey's peer group average for short interest as a percentage of float is 3.14%, which ...

Revelyst and Strategic Value Partners today announced that SVP-managed funds have completed their previously announced ...

Houlihan Lokey, Inc. has a 12 month low of $112.17 and a 12 month high of $192.10. The company’s fifty day moving average price is $179.29 and its two-hundred day moving average price is $159.23.

The transaction is not subject to a financing condition. TD Securities and Houlihan Lokey are serving as financial advisors to the Special Committee of the Singular Genomics Board of Directors, ...

Explore the exciting world of Houlihan Lokey(NYSE: HLI) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and ...

The Paris-headquartered firm closed Mantra Secondary Opportunities III on €180 million against a €150 million target in 2021, ...

In recent trading, shares of Houlihan Lokey Inc (Symbol: HLI) have crossed above the average analyst 12-month target price of $173.28, changing hands for $173.97/share. When a stock reaches the ...